nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Blood pressure increased—Desonide—atopic dermatitis	0.0361	0.0699	CcSEcCtD
Droxidopa—Myocardial ischaemia—Tacrolimus—atopic dermatitis	0.0172	0.0334	CcSEcCtD
Droxidopa—Cardiac failure congestive—Tacrolimus—atopic dermatitis	0.0111	0.0215	CcSEcCtD
Droxidopa—Confusional state—Dimenhydrinate—atopic dermatitis	0.00948	0.0184	CcSEcCtD
Droxidopa—Confusional state—Diphenhydramine—atopic dermatitis	0.00948	0.0184	CcSEcCtD
Droxidopa—Urinary tract infection—Mometasone—atopic dermatitis	0.00947	0.0184	CcSEcCtD
Droxidopa—Arrhythmia—Loratadine—atopic dermatitis	0.00911	0.0177	CcSEcCtD
Droxidopa—Headache—Desonide—atopic dermatitis	0.00806	0.0156	CcSEcCtD
Droxidopa—Syncope—Loratadine—atopic dermatitis	0.00796	0.0154	CcSEcCtD
Droxidopa—Loss of consciousness—Loratadine—atopic dermatitis	0.0078	0.0151	CcSEcCtD
Droxidopa—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.00775	0.015	CcSEcCtD
Droxidopa—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.00775	0.015	CcSEcCtD
Droxidopa—Hypertension—Loratadine—atopic dermatitis	0.00766	0.0149	CcSEcCtD
Droxidopa—Urinary tract infection—Tacrolimus—atopic dermatitis	0.00754	0.0146	CcSEcCtD
Droxidopa—Shock—Loratadine—atopic dermatitis	0.00713	0.0138	CcSEcCtD
Droxidopa—Cardiac failure congestive—Prednisolone—atopic dermatitis	0.00709	0.0137	CcSEcCtD
Droxidopa—Cardiac failure congestive—Hydrocortisone—atopic dermatitis	0.00692	0.0134	CcSEcCtD
Droxidopa—Dizziness—Fluocinonide—atopic dermatitis	0.0069	0.0134	CcSEcCtD
Droxidopa—Headache—Fluocinonide—atopic dermatitis	0.00653	0.0127	CcSEcCtD
Droxidopa—Cardiac failure congestive—Triamcinolone—atopic dermatitis	0.00652	0.0126	CcSEcCtD
Droxidopa—Cardiac failure congestive—Methylprednisolone—atopic dermatitis	0.0065	0.0126	CcSEcCtD
Droxidopa—Arrhythmia—Tacrolimus—atopic dermatitis	0.00622	0.0121	CcSEcCtD
Droxidopa—Dizziness—Dimenhydrinate—atopic dermatitis	0.00622	0.0121	CcSEcCtD
Droxidopa—Dizziness—Diphenhydramine—atopic dermatitis	0.00622	0.0121	CcSEcCtD
Droxidopa—Feeling abnormal—Loratadine—atopic dermatitis	0.00597	0.0116	CcSEcCtD
Droxidopa—Cardiac failure congestive—Dexamethasone—atopic dermatitis	0.00592	0.0115	CcSEcCtD
Droxidopa—Cardiac failure congestive—Betamethasone—atopic dermatitis	0.00592	0.0115	CcSEcCtD
Droxidopa—Headache—Diphenhydramine—atopic dermatitis	0.00589	0.0114	CcSEcCtD
Droxidopa—Headache—Dimenhydrinate—atopic dermatitis	0.00589	0.0114	CcSEcCtD
Droxidopa—Headache—Pimecrolimus—atopic dermatitis	0.0057	0.011	CcSEcCtD
Droxidopa—Nausea—Diphenhydramine—atopic dermatitis	0.00559	0.0108	CcSEcCtD
Droxidopa—Nausea—Dimenhydrinate—atopic dermatitis	0.00559	0.0108	CcSEcCtD
Droxidopa—Syncope—Tacrolimus—atopic dermatitis	0.00544	0.0105	CcSEcCtD
Droxidopa—Nausea—Pimecrolimus—atopic dermatitis	0.0054	0.0105	CcSEcCtD
Droxidopa—Loss of consciousness—Tacrolimus—atopic dermatitis	0.00533	0.0103	CcSEcCtD
Droxidopa—Hypertension—Tacrolimus—atopic dermatitis	0.00523	0.0101	CcSEcCtD
Droxidopa—Cardiac failure congestive—Prednisone—atopic dermatitis	0.00515	0.00999	CcSEcCtD
Droxidopa—Confusional state—Tacrolimus—atopic dermatitis	0.00499	0.00967	CcSEcCtD
Droxidopa—Shock—Tacrolimus—atopic dermatitis	0.00487	0.00944	CcSEcCtD
Droxidopa—Dizziness—Loratadine—atopic dermatitis	0.00479	0.00928	CcSEcCtD
Droxidopa—Headache—Loratadine—atopic dermatitis	0.00454	0.0088	CcSEcCtD
Droxidopa—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.0043	0.00834	CcSEcCtD
Droxidopa—Nausea—Loratadine—atopic dermatitis	0.0043	0.00834	CcSEcCtD
Droxidopa—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00408	0.00791	CcSEcCtD
Droxidopa—Feeling abnormal—Tacrolimus—atopic dermatitis	0.00408	0.0079	CcSEcCtD
Droxidopa—Arrhythmia—Prednisolone—atopic dermatitis	0.00397	0.0077	CcSEcCtD
Droxidopa—Headache—Mometasone—atopic dermatitis	0.00389	0.00755	CcSEcCtD
Droxidopa—Arrhythmia—Hydrocortisone—atopic dermatitis	0.00388	0.00752	CcSEcCtD
Droxidopa—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00387	0.0075	CcSEcCtD
Droxidopa—Nausea—Mometasone—atopic dermatitis	0.00369	0.00716	CcSEcCtD
Droxidopa—Arrhythmia—Triamcinolone—atopic dermatitis	0.00365	0.00708	CcSEcCtD
Droxidopa—Arrhythmia—Methylprednisolone—atopic dermatitis	0.00365	0.00707	CcSEcCtD
Droxidopa—Syncope—Prednisolone—atopic dermatitis	0.00347	0.00673	CcSEcCtD
Droxidopa—Loss of consciousness—Prednisolone—atopic dermatitis	0.0034	0.0066	CcSEcCtD
Droxidopa—Syncope—Hydrocortisone—atopic dermatitis	0.00339	0.00657	CcSEcCtD
Droxidopa—Hypertension—Prednisolone—atopic dermatitis	0.00334	0.00648	CcSEcCtD
Droxidopa—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.00332	0.00644	CcSEcCtD
Droxidopa—Arrhythmia—Dexamethasone—atopic dermatitis	0.00332	0.00643	CcSEcCtD
Droxidopa—Arrhythmia—Betamethasone—atopic dermatitis	0.00332	0.00643	CcSEcCtD
Droxidopa—Dizziness—Tacrolimus—atopic dermatitis	0.00327	0.00634	CcSEcCtD
Droxidopa—Hypertension—Hydrocortisone—atopic dermatitis	0.00326	0.00633	CcSEcCtD
Droxidopa—Syncope—Triamcinolone—atopic dermatitis	0.00319	0.00619	CcSEcCtD
Droxidopa—Syncope—Methylprednisolone—atopic dermatitis	0.00319	0.00618	CcSEcCtD
Droxidopa—Loss of consciousness—Triamcinolone—atopic dermatitis	0.00313	0.00607	CcSEcCtD
Droxidopa—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.00312	0.00605	CcSEcCtD
Droxidopa—Shock—Prednisolone—atopic dermatitis	0.00311	0.00603	CcSEcCtD
Droxidopa—Headache—Tacrolimus—atopic dermatitis	0.0031	0.00601	CcSEcCtD
Droxidopa—Hypertension—Triamcinolone—atopic dermatitis	0.00307	0.00596	CcSEcCtD
Droxidopa—Hypertension—Methylprednisolone—atopic dermatitis	0.00307	0.00595	CcSEcCtD
Droxidopa—Shock—Hydrocortisone—atopic dermatitis	0.00304	0.00589	CcSEcCtD
Droxidopa—Nausea—Tacrolimus—atopic dermatitis	0.00294	0.0057	CcSEcCtD
Droxidopa—Confusional state—Methylprednisolone—atopic dermatitis	0.00292	0.00567	CcSEcCtD
Droxidopa—Syncope—Dexamethasone—atopic dermatitis	0.0029	0.00562	CcSEcCtD
Droxidopa—Syncope—Betamethasone—atopic dermatitis	0.0029	0.00562	CcSEcCtD
Droxidopa—Arrhythmia—Prednisone—atopic dermatitis	0.00289	0.0056	CcSEcCtD
Droxidopa—Shock—Triamcinolone—atopic dermatitis	0.00286	0.00554	CcSEcCtD
Droxidopa—Shock—Methylprednisolone—atopic dermatitis	0.00285	0.00553	CcSEcCtD
Droxidopa—Loss of consciousness—Betamethasone—atopic dermatitis	0.00284	0.0055	CcSEcCtD
Droxidopa—Loss of consciousness—Dexamethasone—atopic dermatitis	0.00284	0.0055	CcSEcCtD
Droxidopa—Hypertension—Betamethasone—atopic dermatitis	0.00279	0.00541	CcSEcCtD
Droxidopa—Hypertension—Dexamethasone—atopic dermatitis	0.00279	0.00541	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisolone—atopic dermatitis	0.0026	0.00505	CcSEcCtD
Droxidopa—Shock—Dexamethasone—atopic dermatitis	0.00259	0.00503	CcSEcCtD
Droxidopa—Shock—Betamethasone—atopic dermatitis	0.00259	0.00503	CcSEcCtD
Droxidopa—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.00254	0.00493	CcSEcCtD
Droxidopa—Syncope—Prednisone—atopic dermatitis	0.00252	0.00489	CcSEcCtD
Droxidopa—Loss of consciousness—Prednisone—atopic dermatitis	0.00247	0.00479	CcSEcCtD
Droxidopa—Hypertension—Prednisone—atopic dermatitis	0.00243	0.00471	CcSEcCtD
Droxidopa—Feeling abnormal—Triamcinolone—atopic dermatitis	0.00239	0.00464	CcSEcCtD
Droxidopa—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.00239	0.00463	CcSEcCtD
Droxidopa—Shock—Prednisone—atopic dermatitis	0.00226	0.00438	CcSEcCtD
Droxidopa—Feeling abnormal—Dexamethasone—atopic dermatitis	0.00217	0.00421	CcSEcCtD
Droxidopa—Feeling abnormal—Betamethasone—atopic dermatitis	0.00217	0.00421	CcSEcCtD
Droxidopa—Dizziness—Prednisolone—atopic dermatitis	0.00209	0.00405	CcSEcCtD
Droxidopa—Dizziness—Hydrocortisone—atopic dermatitis	0.00204	0.00396	CcSEcCtD
Droxidopa—Headache—Prednisolone—atopic dermatitis	0.00198	0.00384	CcSEcCtD
Droxidopa—Headache—Hydrocortisone—atopic dermatitis	0.00193	0.00375	CcSEcCtD
Droxidopa—Dizziness—Triamcinolone—atopic dermatitis	0.00192	0.00373	CcSEcCtD
Droxidopa—Dizziness—Methylprednisolone—atopic dermatitis	0.00192	0.00372	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisone—atopic dermatitis	0.00189	0.00367	CcSEcCtD
Droxidopa—Nausea—Prednisolone—atopic dermatitis	0.00188	0.00364	CcSEcCtD
Droxidopa—Nausea—Hydrocortisone—atopic dermatitis	0.00183	0.00355	CcSEcCtD
Droxidopa—Headache—Triamcinolone—atopic dermatitis	0.00182	0.00353	CcSEcCtD
Droxidopa—Headache—Methylprednisolone—atopic dermatitis	0.00182	0.00352	CcSEcCtD
Droxidopa—Dizziness—Dexamethasone—atopic dermatitis	0.00174	0.00338	CcSEcCtD
Droxidopa—Dizziness—Betamethasone—atopic dermatitis	0.00174	0.00338	CcSEcCtD
Droxidopa—Nausea—Triamcinolone—atopic dermatitis	0.00173	0.00335	CcSEcCtD
Droxidopa—Nausea—Methylprednisolone—atopic dermatitis	0.00172	0.00334	CcSEcCtD
Droxidopa—Headache—Betamethasone—atopic dermatitis	0.00165	0.0032	CcSEcCtD
Droxidopa—Headache—Dexamethasone—atopic dermatitis	0.00165	0.0032	CcSEcCtD
Droxidopa—Nausea—Betamethasone—atopic dermatitis	0.00157	0.00304	CcSEcCtD
Droxidopa—Nausea—Dexamethasone—atopic dermatitis	0.00157	0.00304	CcSEcCtD
Droxidopa—Dizziness—Prednisone—atopic dermatitis	0.00152	0.00294	CcSEcCtD
Droxidopa—Headache—Prednisone—atopic dermatitis	0.00144	0.00279	CcSEcCtD
Droxidopa—Nausea—Prednisone—atopic dermatitis	0.00136	0.00264	CcSEcCtD
Droxidopa—ADRA1D—GPCR ligand binding—CXCL8—atopic dermatitis	0.000268	0.000553	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCR3—atopic dermatitis	0.000268	0.000553	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000267	0.000552	CbGpPWpGaD
Droxidopa—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000267	0.000551	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CXCL10—atopic dermatitis	0.000266	0.000549	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CXCL10—atopic dermatitis	0.000265	0.000547	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000261	0.00054	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL5—atopic dermatitis	0.000259	0.000536	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000259	0.000536	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—STAT6—atopic dermatitis	0.000258	0.000532	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL17—atopic dermatitis	0.000256	0.000528	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—STAT6—atopic dermatitis	0.000255	0.000527	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL11—atopic dermatitis	0.000254	0.000524	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CMA1—atopic dermatitis	0.000254	0.000524	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL5—atopic dermatitis	0.000254	0.000524	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TAC1—atopic dermatitis	0.000253	0.000523	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—NPS—atopic dermatitis	0.000253	0.000523	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000253	0.000523	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CCL5—atopic dermatitis	0.000252	0.000521	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—STAT6—atopic dermatitis	0.000252	0.000521	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CCL5—atopic dermatitis	0.000251	0.000518	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—CCR5—atopic dermatitis	0.00025	0.000517	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL11—atopic dermatitis	0.00025	0.000516	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CMA1—atopic dermatitis	0.00025	0.000516	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCR3—atopic dermatitis	0.000249	0.000513	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CCL5—atopic dermatitis	0.000248	0.000512	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CXCL10—atopic dermatitis	0.000247	0.000511	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—KIF3A—atopic dermatitis	0.000245	0.000507	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCR3—atopic dermatitis	0.000245	0.000507	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000244	0.000504	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CXCL10—atopic dermatitis	0.000243	0.000503	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—CXCL8—atopic dermatitis	0.000242	0.0005	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000241	0.000498	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—CXCL8—atopic dermatitis	0.000239	0.000493	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—STAT6—atopic dermatitis	0.000239	0.000493	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000238	0.000492	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL5—atopic dermatitis	0.000236	0.000487	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—STAT6—atopic dermatitis	0.000235	0.000485	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CCL5—atopic dermatitis	0.000234	0.000484	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000232	0.00048	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CCL5—atopic dermatitis	0.000231	0.000477	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CCL5—atopic dermatitis	0.00023	0.000475	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCL5—atopic dermatitis	0.000229	0.000473	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000228	0.000471	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CCL5—atopic dermatitis	0.000228	0.000471	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—KIF3A—atopic dermatitis	0.000228	0.000471	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CCR5—atopic dermatitis	0.000227	0.00047	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CCR5—atopic dermatitis	0.000226	0.000467	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—CXCL8—atopic dermatitis	0.000226	0.000467	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CCL5—atopic dermatitis	0.000225	0.000465	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCR3—atopic dermatitis	0.000223	0.000462	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000223	0.000461	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—CXCL8—atopic dermatitis	0.000222	0.000459	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—IL2—atopic dermatitis	0.000222	0.000459	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL11—atopic dermatitis	0.000222	0.000458	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CMA1—atopic dermatitis	0.000222	0.000458	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000222	0.000458	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCR3—atopic dermatitis	0.000221	0.000457	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000221	0.000457	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCR3—atopic dermatitis	0.000219	0.000451	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TAC1—atopic dermatitis	0.000219	0.000451	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NPS—atopic dermatitis	0.000219	0.000451	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCL10—atopic dermatitis	0.000216	0.000447	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCR3—atopic dermatitis	0.000214	0.000443	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CCL5—atopic dermatitis	0.000213	0.00044	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NGF—atopic dermatitis	0.000212	0.000438	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CCR5—atopic dermatitis	0.000211	0.000436	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CXCL8—atopic dermatitis	0.000211	0.000436	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CCL5—atopic dermatitis	0.00021	0.000433	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—STAT6—atopic dermatitis	0.000209	0.000431	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CCR5—atopic dermatitis	0.000208	0.000429	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CCR5—atopic dermatitis	0.000207	0.000428	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR3—atopic dermatitis	0.000207	0.000427	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—IL2—atopic dermatitis	0.000207	0.000427	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCR5—atopic dermatitis	0.000206	0.000426	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	0.000206	0.000426	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CMA1—atopic dermatitis	0.000206	0.000426	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CCR5—atopic dermatitis	0.000205	0.000424	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CCL5—atopic dermatitis	0.000205	0.000423	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR3—atopic dermatitis	0.000204	0.00042	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL5—atopic dermatitis	0.000203	0.00042	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CCR5—atopic dermatitis	0.000203	0.000419	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL2—atopic dermatitis	0.000202	0.000417	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	0.000201	0.000415	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NPS—atopic dermatitis	0.000199	0.000411	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TAC1—atopic dermatitis	0.000199	0.000411	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CXCL8—atopic dermatitis	0.000198	0.000408	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NPS—atopic dermatitis	0.000197	0.000408	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TAC1—atopic dermatitis	0.000197	0.000408	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000197	0.000406	CbGpPWpGaD
Droxidopa—PAH—Disease—IL6—atopic dermatitis	0.000196	0.000404	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCR3—atopic dermatitis	0.000195	0.000403	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NPS—atopic dermatitis	0.000195	0.000402	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TAC1—atopic dermatitis	0.000195	0.000402	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	0.000194	0.0004	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCR3—atopic dermatitis	0.000194	0.0004	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—IL2—atopic dermatitis	0.000193	0.000399	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CCR5—atopic dermatitis	0.000192	0.000396	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCR3—atopic dermatitis	0.000191	0.000395	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	0.00019	0.000393	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CCR5—atopic dermatitis	0.000189	0.00039	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	0.000186	0.000384	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL5—atopic dermatitis	0.000185	0.000382	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	0.000185	0.000381	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NPS—atopic dermatitis	0.000184	0.000381	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TAC1—atopic dermatitis	0.000184	0.000381	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	0.000184	0.000379	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL5—atopic dermatitis	0.000183	0.000379	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TAC1—atopic dermatitis	0.000181	0.000375	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NPS—atopic dermatitis	0.000181	0.000375	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL5—atopic dermatitis	0.000181	0.000374	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	0.000181	0.000373	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCR3—atopic dermatitis	0.000181	0.000373	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCR3—atopic dermatitis	0.000178	0.000367	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NFKBIA—atopic dermatitis	0.000175	0.000361	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCL10—atopic dermatitis	0.000173	0.000358	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	0.000173	0.000357	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	0.000172	0.000354	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	0.000171	0.000354	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	0.000169	0.000348	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	0.000168	0.000347	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	0.000168	0.000346	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	0.000161	0.000333	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	0.000161	0.000333	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	0.000158	0.000326	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	0.000158	0.000326	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IL2—atopic dermatitis	0.000157	0.000324	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	0.000156	0.000323	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	0.000156	0.000322	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	0.000154	0.000319	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000151	0.000313	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	0.00015	0.000309	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	0.00015	0.000309	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	0.00015	0.000309	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	0.000149	0.000308	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	0.000147	0.000303	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	0.000146	0.000302	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	0.000145	0.000299	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	0.000144	0.000297	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	0.000139	0.000287	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	0.000138	0.000285	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000138	0.000285	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	0.000138	0.000284	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000137	0.000282	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	0.000136	0.000281	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000135	0.000279	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	0.000135	0.000278	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	0.000134	0.000278	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	0.000133	0.000275	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	0.000132	0.000272	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	0.000131	0.000271	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	0.000131	0.00027	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PPARA—atopic dermatitis	0.00013	0.000268	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	0.000129	0.000266	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	0.000128	0.000264	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000128	0.000264	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NGF—atopic dermatitis	0.000126	0.00026	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	0.000126	0.00026	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000126	0.00026	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000125	0.000259	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CXCL8—atopic dermatitis	0.000125	0.000258	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	0.000125	0.000258	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	0.000124	0.000256	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	0.000124	0.000256	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NGF—atopic dermatitis	0.000123	0.000254	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	0.000123	0.000253	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	0.000122	0.000253	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	0.000122	0.000252	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	0.000121	0.000251	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	0.00012	0.000248	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	0.00012	0.000247	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	0.00012	0.000247	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL2—atopic dermatitis	0.000119	0.000246	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	0.000119	0.000245	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	0.000119	0.000245	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL6—atopic dermatitis	0.000119	0.000245	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	0.000117	0.000242	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	0.000116	0.000241	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	0.000116	0.00024	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	0.000115	0.000237	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	0.000114	0.000236	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	0.000114	0.000235	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	0.000113	0.000234	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000112	0.000231	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	0.000112	0.00023	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	0.000111	0.000229	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	0.00011	0.000227	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MAPK8—atopic dermatitis	0.00011	0.000227	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	0.000109	0.000225	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	0.000107	0.00022	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PPARA—atopic dermatitis	0.000106	0.000218	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000104	0.000214	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000104	0.000214	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	0.000103	0.000212	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	0.000102	0.000211	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	0.000102	0.00021	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	0.000102	0.00021	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	0.000101	0.000209	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	9.91e-05	0.000205	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	9.91e-05	0.000205	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	9.69e-05	0.0002	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	9.61e-05	0.000198	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	9.46e-05	0.000195	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	9.45e-05	0.000195	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	9.42e-05	0.000195	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	9.2e-05	0.00019	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	9e-05	0.000186	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	8.4e-05	0.000173	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	8.12e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	7.8e-05	0.000161	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	7.76e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	7.72e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	7.4e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	7.33e-05	0.000151	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	7.24e-05	0.00015	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	7.15e-05	0.000148	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2—atopic dermatitis	7.07e-05	0.000146	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	7.04e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	7.01e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—atopic dermatitis	7e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	6.97e-05	0.000144	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2—atopic dermatitis	6.92e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	6.88e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	6.85e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	6.74e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	6.55e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	6.51e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	6.51e-05	0.000134	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	6.45e-05	0.000133	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	6.44e-05	0.000133	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	6.41e-05	0.000132	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	6.37e-05	0.000132	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	6.03e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	5.99e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	5.93e-05	0.000123	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	5.72e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	5.69e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	5.56e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	5.32e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	5.29e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	5.27e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	4.89e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	4.56e-05	9.43e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—atopic dermatitis	4.16e-05	8.59e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	4.12e-05	8.51e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—atopic dermatitis	4.07e-05	8.4e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	3.85e-05	7.95e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	3.79e-05	7.82e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	3.36e-05	6.95e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	3.13e-05	6.46e-05	CbGpPWpGaD
